Acquisition of OMAVELOXOLONA 50 MG CAPS

This tender concerns the acquisition of a specific pharmaceutical product: OMAVELOXOLONA 50 MG CAPS (50 mg capsules of OMAVELOXOLONA). OMAVELOXOLONA is a medication, likely used for therapeutic purposes. The procurement procedure is 'Contratação excluída II', indicating an excluded procurement contract under specific regulations, possibly due to the nature of the goods or specific exemptions. The base price for this acquisition is substantial, amounting to €1,113,600.10, suggesting a significant quantity or high unit cost of the medication. This procurement is essential for healthcare providers to ensure the availability of this specific drug for patient treatment, likely within a hospital or clinical setting.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.1 million.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.